Browsing: Medication & Drugs

Survodutide pairs GLP-1 with glucagon receptor activity. Could hepatic metabolism and energy expenditure translate into an advantage over GLP-1/GIP therapies?

Log In or Register as a healthcare professional to read the full article.

Weight-loss drugs are facing a bowel cancer question, but the findings are far from settled. We unpack the GLP-1 research, the distinction between polyps and cancer, and what patients should discuss with their doctor.